These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10523129)

  • 41. [Floracide, a Russian 3rd generation fluoroquinolone in complex therapy of tuberculosis].
    Sokolova GB; Kirtaeva OV; Lazareva IaV; Tsybanev AA
    Antibiot Khimioter; 2008; 53(5-6):28-31. PubMed ID: 19069179
    [No Abstract]   [Full Text] [Related]  

  • 42. [The role of bacteriology in the treatment of tuberculosis; the Hungarian program].
    Fodor T
    Orv Hetil; 2000 Sep; 141(36):1981-3. PubMed ID: 11031835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Failing a re-treatment regimen does not predict MDR/XDR tuberculosis: is "blind" treatment dangerous?
    Badoum G; Saleri N; Dembélé MS; Ouedraogo M; Pinsi G; Boncoungou K; Bonkoungou V; Birba E; Miotto P; Migliori GB; Cirillo DM; Matteelli A
    Eur Respir J; 2011 May; 37(5):1283-5. PubMed ID: 21532018
    [No Abstract]   [Full Text] [Related]  

  • 44. WHO recommendations for multidrug-resistant tuberculosis - Authors' reply.
    Sotgiu G; Tiberi S; D'Ambrosio L; Centis R; Zumla A; Migliori GB
    Lancet; 2016 Nov; 388(10057):2234-2235. PubMed ID: 27825499
    [No Abstract]   [Full Text] [Related]  

  • 45. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug-resistant tuberculosis: reality and potential threat.
    Lalloo UG
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):255-8. PubMed ID: 20132610
    [No Abstract]   [Full Text] [Related]  

  • 47. [Chinese expert consensus on multidrug-resistant tuberculosis and Rifampicin-resistant tuberculosis treatment].
    Chinese Society of Tuberculosis of Chinese Medical Association
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):733-749. PubMed ID: 31594107
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen.
    Achar J; Berry C; Herboczek K; Parpieva N; Tillyashaykhov MN; Tigay ZN; Khamraev A; Velivela K; Seddon JA; du Cros P
    Emerg Infect Dis; 2015 Nov; 21(11):2105-6. PubMed ID: 26488556
    [No Abstract]   [Full Text] [Related]  

  • 49. Acquisition of Rifampin Resistance in Pulmonary Tuberculosis.
    Kayigire XA; Friedrich SO; van der Merwe L; Diacon AH
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167550
    [No Abstract]   [Full Text] [Related]  

  • 50. [Use of native and lyophilized Loewenstein-Jensen's solid media in determining drug resistance on mycobacterium tuberculosis strains].
    Korneev AA; Golyshevskaia VI; Sevast'ianova EV; Safonova SG; Puzanov VA; Maslennikova IuV; Katulina NI; Stoiunin MB
    Probl Tuberk; 1999; (4):25-7. PubMed ID: 10479928
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Back to the future: a new 'old' lead for tuberculosis.
    Wright GD
    EMBO Mol Med; 2012 Oct; 4(10):1029-31. PubMed ID: 22987753
    [No Abstract]   [Full Text] [Related]  

  • 52. [Management of multidrug-resistant tuberculosis].
    Tritar F; Daghfous H; Ben Saad S; Slim-Saidi L
    Rev Pneumol Clin; 2015; 71(2-3):130-9. PubMed ID: 25153927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High rates of multidrug-resistant Mycobacterium tuberculosis in Sinaloa State, Mexico.
    Zazueta-Beltran J; Muro-Amador S; Flores-Gaxiola A; Llausas-Magaña E; León-Sicairos N; Canizalez-Roman A
    J Infect; 2007 Apr; 54(4):411-2. PubMed ID: 16730800
    [No Abstract]   [Full Text] [Related]  

  • 54. Nomenclature of drug-resistant tuberculosis.
    Udwadia ZF; Amale RA; Ajbani KK; Rodrigues CS
    Lancet Infect Dis; 2013 Nov; 13(11):917. PubMed ID: 24156895
    [No Abstract]   [Full Text] [Related]  

  • 55. How are we creating fluoroquinolone-resistant tuberculosis?
    Bernardo J; Yew WW
    Am J Respir Crit Care Med; 2009 Aug; 180(4):288-9. PubMed ID: 19661251
    [No Abstract]   [Full Text] [Related]  

  • 56. Pattern of drug-resistance and treatment outcome in multidrug-resistant pulmonary tuberculosis.
    Nagaraja C; Shashibhushan BL; Asif M; Manjunath PH; Sagar C
    Indian J Chest Dis Allied Sci; 2012; 54(1):23-6. PubMed ID: 22779119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Discussing on multidrug-resistant tuberculosis for surgery].
    Song YZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 May; 42(5):338-342. PubMed ID: 31137110
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparison of clinical characteristics between rifampin-dependent and rifampin- resistant patients with pulmonary tuberculosis].
    Li Y; Tan S; Luo C; Li Y; Qin H; Feng Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):287-9. PubMed ID: 23443791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid impact of effective chemotherapy on transmission of drug-resistant tuberculosis: pity the guinea pig.
    Farmer PE; Raviglione MC
    Int J Tuberc Lung Dis; 2014 Sep; 18(9):1009-11. PubMed ID: 25189545
    [No Abstract]   [Full Text] [Related]  

  • 60. Drug-resistant tuberculosis.
    Böttger EC
    Lancet; 2001 Apr; 357(9264):1288-9. PubMed ID: 11421208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.